Guggenheim Maintains Krystal Biotech (KRYS) Buy Recommendation
- Stock Market Stocks to buy Stocks to sell
admin
- 0
- 1 minute read
Fintel reports that on May 22, 2023, Guggenheim maintained coverage of Krystal Biotech (NASDAQ:KRYS) with a Buy recommendation.
:max_bytes(150000):strip_icc():format(jpeg)/KraftCadburyHostileTakeover-56143341d0004032a1cdb65ec3c2859b.jpg "What Are Some Top Examples of Hostile Takeovers?")
